These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 30121715)

  • 1. Management of Brain Metastases in the New Era of Checkpoint Inhibition.
    Lauko A; Thapa B; Venur VA; Ahluwalia MS
    Curr Neurol Neurosci Rep; 2018 Aug; 18(10):70. PubMed ID: 30121715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
    Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic therapy for brain metastases.
    Venur VA; Karivedu V; Ahluwalia MS
    Handb Clin Neurol; 2018; 149():137-153. PubMed ID: 29307351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Checkpoint Inhibitors for Brain Metastases.
    Tan AC; Heimberger AB; Menzies AM; Pavlakis N; Khasraw M
    Curr Oncol Rep; 2017 Jun; 19(6):38. PubMed ID: 28417311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy Plus Stereotactic Radiosurgery: Building on the Promise of Precision Medicine for CNS Malignancies-PART 1: Principles of Combined Treatment.
    Zhang I; Formenti SC; Knisely JPS
    Oncology (Williston Park); 2018 Feb; 32(2):e28-e32. PubMed ID: 29492951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases.
    Lehrer EJ; McGee HM; Peterson JL; Vallow L; Ruiz-Garcia H; Zaorsky NG; Sharma S; Trifiletti DM
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Melanoma brain metastases : Treatment options].
    Rauschenberg R; Tabatabai G; Troost EG; Garzarolli M; Beissert S; Meier F
    Hautarzt; 2016 Jul; 67(7):536-43. PubMed ID: 27206449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiosurgery combined with immune checkpoint inhibitors or kinase inhibitors for patients with multiple brain metastases of malignant melanoma.
    Stera S; Balermpas P; Blanck O; Wolff R; Wurster S; Baumann R; Szücs M; Loutfi-Krauss B; Wilhelm ML; Seifert V; Rades D; Rödel C; Dunst J; Hildebrandt G; Arnold A; Meissner M; Kähler KC
    Melanoma Res; 2019 Apr; 29(2):187-195. PubMed ID: 30802230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosurgery and Immunotherapy in the Treatment of Brain Metastases.
    Ramakrishna R; Formenti S
    World Neurosurg; 2019 Oct; 130():615-622. PubMed ID: 31581411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing Therapeutic Landscape for Melanoma With Multiple Brain Metastases.
    Jiang C; Wallington DG; Anker CJ; Lawson DH; Yushak ML; Kudchadkar RR; Tarhini A; Khan MK
    Neurosurgery; 2020 Sep; 87(3):498-515. PubMed ID: 32315430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The forgotten role of adjuvant immune checkpoint inhibitors in preventing melanoma brain metastasis.
    El Rassy E; Farhat F; Kattan J
    Immunotherapy; 2018 Nov; 10(15):1289-1291. PubMed ID: 30474477
    [No Abstract]   [Full Text] [Related]  

  • 12. Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment.
    Anderson ES; Postow MA; Wolchok JD; Young RJ; Ballangrud Å; Chan TA; Yamada Y; Beal K
    J Immunother Cancer; 2017 Oct; 5(1):76. PubMed ID: 29037215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Brain Metastases in Non-Small-Cell Lung Cancer.
    Ernani V; Stinchcombe TE
    J Oncol Pract; 2019 Nov; 15(11):563-570. PubMed ID: 31715122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
    Mahoney KM; Freeman GJ; McDermott DF
    Clin Ther; 2015 Apr; 37(4):764-82. PubMed ID: 25823918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes.
    Gabani P; Fischer-Valuck BW; Johanns TM; Hernandez-Aya LF; Keller JW; Rich KM; Kim AH; Dunn GP; Robinson CG; Chicoine MR; Huang J; Abraham CD
    Radiother Oncol; 2018 Aug; 128(2):266-273. PubMed ID: 29960685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases?
    Franceschini D; Franzese C; Navarria P; Ascolese AM; De Rose F; Del Vecchio M; Santoro A; Scorsetti M
    Cancer Treat Rev; 2016 Nov; 50():1-8. PubMed ID: 27566962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of brain metastases in patients with melanoma.
    Tarhini AA; Agarwala SS
    Curr Opin Oncol; 2004 Mar; 16(2):161-6. PubMed ID: 15075910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic therapies for melanoma brain metastases: which drug for whom and when?
    Ramanujam S; Schadendorf D; Long GV
    Chin Clin Oncol; 2015 Jun; 4(2):25. PubMed ID: 26112811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: A systematic review.
    Spagnolo F; Picasso V; Lambertini M; Ottaviano V; Dozin B; Queirolo P
    Cancer Treat Rev; 2016 Apr; 45():38-45. PubMed ID: 26975020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined irradiation and targeted therapy or immune checkpoint blockade in brain metastases: toxicities and efficacy.
    Tallet AV; Dhermain F; Le Rhun E; Noël G; Kirova YM
    Ann Oncol; 2017 Dec; 28(12):2962-2976. PubMed ID: 29045524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.